Stay updated on Long-Term Upadacitinib in Crohn's Disease Clinical Trial
Sign up to get notified when there's something new on the Long-Term Upadacitinib in Crohn's Disease Clinical Trial page.

Latest updates to the Long-Term Upadacitinib in Crohn's Disease Clinical Trial page
- CheckyesterdayChange DetectedRevision: v3.5.2 has been added and Revision: v3.5.0 has been removed.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check30 days agoChange Detected- Revision: v3.5.0 applied; previously v3.4.3.SummaryDifference0.0%

- Check37 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3 on the page. This appears to be a minor site update with no changes to study data, eligibility criteria, or other core content.SummaryDifference0.0%

- Check65 days agoChange DetectedRevision: v3.4.2 was added to the page, and the prior notice about government funding lapse and operating status (Revision: v3.4.1) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check72 days agoChange DetectedAdded a government funding notice regarding possible disruptions and updated the site from Revision: v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check79 days agoChange DetectedAdded Show glossary option and QC metadata (Last Update Submitted that Met QC Criteria) along with a Revision: v3.4.0 and standardized No FEAR Act wording. Removed the older QC label ('Last Update Submitted that met QC Criteria'), the lowercase 'No FEAR Act data' wording, and the prior Revision: v3.3.4.SummaryDifference0.1%

Stay in the know with updates to Long-Term Upadacitinib in Crohn's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-Term Upadacitinib in Crohn's Disease Clinical Trial page.